Increased cancer mortality following history of nonmelanoma skin cancer

JAMA

Volumn 280, Issue 10, 1998, Pages 910-912

  Kahn, Henry S ^a,c   Tatham, Lilith M ^b   Patel, Alpa V ^d   Thun, Michael J ^c   Heath, Clark W ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER MORTALITY; CAUSE OF DEATH; FEMALE; HUMAN; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SALIVARY GLAND CANCER; SKIN CANCER; TESTIS CANCER;

EID: 0032500308     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.10.910     Document Type: Article

References (30)

1. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol. 1995; 141:916-922.
2. Levi F, Randimbison L, La Vecchia C, Erler G, Te V-C. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol. 1997; 146:734-739.
3. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. Ann Intern Med. 1996;125:815-821.
4. Teppo L, Pukkala E, Saxen E. Multiple cancer. J Natl Cancer Inst. 1985;75:207-217.
5. Schottenfeld D. Basal-cell carcinoma of the skin. Ann Intern Med. 1996;125:852-854.
6. Garfinkel L, Heath CW. Cancer Prevention Study II. Stat Bull Metrop Insur Co. 1992;73:21-29.
7. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of morality among Cancer Prevention Study II participants. Am J Epidemiol. 1993;137:235-241.
8. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
9. Leigh IM, Newton Bishop JA, Kripke ML. Skin cancer: introduction. Cancer Surv. 1996;26:1-6.
10. Scotto J, Fears TR, Kraemer KH, Fraumeni JF. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, NY: Oxford University Press; 1996:1313-1330.
11. Kripke ML. Ultraviolet radiation and immunology. Cancer Res. 1994;54:6102-6105.
12. English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control. 1997;8:271-283.
13. Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL). Leukemia Lymphoma. 1994;14:387-394.
14. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies: shared etiology? Int J Cancer. 1995;62:519-522.
15. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ. 1995;310:1491-1495.
16. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer. 1996;73:945-950.
17. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (three-fold) case-control study. BMJ. 1997;314:1451-1455.
18. Newton R. Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin's lymphoma. BMJ. 1997;314:1483-1484.
19. Black HS. Dietary factors in ultraviolet carcinogenesis. Cancer Bull. 1993;45:232-237.
20. Frankel S, Gunnell DJ, Peters TJ, Maynard M, Davey Smith G. Childhood energy intake and adult mortality from cancer. BMJ. 1998;316:499-504.
21. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR. Risk factors for major salivary gland carcinoma. Cancer. 1984;54:1854-1859.
22. Tyring SK. Human papillomaviruses in skin cancer. Cancer Bull. 1993;45:212-219.
23. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer. 1993;72:2198-2206.
24. Boxman ILA, Berkhout RJM, Mulder LHC, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 1997;108: 712-715.
25. Payne DA, Chan TS, Patten B, Tyring SK. Extrachromosomal human papillomavirus (HPV) in multiple myeloma and monoclonal gammopathy of unknown significance (MGUS) patients. Anticancer Res. 1995;15:2213-2215.
26. Shisler JL, Senkevich TG, Berry MJ, Moss B. Ultraviolet-induced cell death blocked by a seleno-protein from a dermatotropic poxvirus. Science. 1998;279:102-105.
27. Au WW, Wilkinson GS, Tyring SK, et al. Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect. 1996;104:579-584.
28. Goldberg LH. Basal-cell carcinoma as predictor for other cancers. Lancet. 1997;349:664-665.
29. Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991;25:245-248.
30. Levi F, La Vecchia C, Te V-C, Randimbison L. Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol. 1998;147:722-726.